These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24382605)

  • 1. Biocompatible and high-performance amino acids-capped MnWO4 nanocasting as a novel non-lanthanide contrast agent for X-ray computed tomography and T(1)-weighted magnetic resonance imaging.
    Dong K; Liu Z; Liu J; Huang S; Li Z; Yuan Q; Ren J; Qu X
    Nanoscale; 2014 Feb; 6(4):2211-7. PubMed ID: 24382605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasmall biomolecule-anchored hybrid GdVO4 nanophosphors as a metabolizable multimodal bioimaging contrast agent.
    Dong K; Ju E; Liu J; Han X; Ren J; Qu X
    Nanoscale; 2014 Oct; 6(20):12042-9. PubMed ID: 25185795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated hybrid ytterbia nanoparticles as high-performance diagnostic probes for in vivo magnetic resonance and X-ray computed tomography imaging with low systemic toxicity.
    Liu Z; Pu F; Liu J; Jiang L; Yuan Q; Li Z; Ren J; Qu X
    Nanoscale; 2013 May; 5(10):4252-61. PubMed ID: 23546530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-biofouling polymer-decorated lutetium-based nanoparticulate contrast agents for in vivo high-resolution trimodal imaging.
    Liu Z; Dong K; Liu J; Han X; Ren J; Qu X
    Small; 2014 Jun; 10(12):2429-38. PubMed ID: 24610806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese-loaded dual-mesoporous silica spheres for efficient T1- and T2-weighted dual mode magnetic resonance imaging.
    Niu D; Luo X; Li Y; Liu X; Wang X; Shi J
    ACS Appl Mater Interfaces; 2013 Oct; 5(20):9942-8. PubMed ID: 24059807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting T1 and T2 dual modality enhanced magnetic resonance imaging of tumor vascular endothelial cells based on peptides-conjugated manganese ferrite nanomicelles.
    Gong M; Yang H; Zhang S; Yang Y; Zhang D; Li Z; Zou L
    Int J Nanomedicine; 2016; 11():4051-63. PubMed ID: 27578974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications.
    Liu Y; Ai K; Lu L
    Acc Chem Res; 2012 Oct; 45(10):1817-27. PubMed ID: 22950890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composition-Tunable Ultrasmall Manganese Ferrite Nanoparticles: Insights into their
    Miao Y; Xie Q; Zhang H; Cai J; Liu X; Jiao J; Hu S; Ghosal A; Yang Y; Fan H
    Theranostics; 2019; 9(6):1764-1776. PubMed ID: 31037137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Ferromagnetic Fe0.6 Mn0.4 O Nanoflowers as a New Class of Magnetic Theranostic Platform for In Vivo T1 -T2 Dual-Mode Magnetic Resonance Imaging and Magnetic Hyperthermia Therapy.
    Liu XL; Ng CT; Chandrasekharan P; Yang HT; Zhao LY; Peng E; Lv YB; Xiao W; Fang J; Yi JB; Zhang H; Chuang KH; Bay BH; Ding J; Fan HM
    Adv Healthc Mater; 2016 Aug; 5(16):2092-104. PubMed ID: 27297640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium complex and phosphorescent probe-modified NaDyF4 nanorods for T1- and T2-weighted MRI/CT/phosphorescence multimodality imaging.
    Zhou J; Lu Z; Shan G; Wang S; Liao Y
    Biomaterials; 2014 Jan; 35(1):368-77. PubMed ID: 24119502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ultrasmall and metabolizable PEGylated NaGdF4:Dy nanoprobe for high-performance T(1)/T(2)-weighted MR and CT multimodal imaging.
    Jin X; Fang F; Liu J; Jiang C; Han X; Song Z; Chen J; Sun G; Lei H; Lu L
    Nanoscale; 2015 Oct; 7(38):15680-8. PubMed ID: 26350491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous synthesis and amine-functionalization of single-phase BaYF5:Yb/Er nanoprobe for dual-modal in vivo upconversion fluorescence and long-lasting X-ray computed tomography imaging.
    Liu H; Lu W; Wang H; Rao L; Yi Z; Zeng S; Hao J
    Nanoscale; 2013 Jul; 5(13):6023-9. PubMed ID: 23715609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characteristics of sub 10 nm manganese oxide T1 contrast agents of different nanostructured morphologies.
    Huang CC; Khu NH; Yeh CS
    Biomaterials; 2010 May; 31(14):4073-8. PubMed ID: 20149451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-step, room-temperature synthesis of glutathione-capped iron-oxide nanoparticles and their application in in vivo T1-weighted magnetic resonance imaging.
    Liu CL; Peng YK; Chou SW; Tseng WH; Tseng YJ; Chen HC; Hsiao JK; Chou PT
    Small; 2014 Oct; 10(19):3962-9. PubMed ID: 25044378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating Anatomic and Functional Dual-Mode Magnetic Resonance Imaging: Design and Applicability of a Bifunctional Contrast Agent.
    Ni D; Shen Z; Zhang J; Zhang C; Wu R; Liu J; Yi M; Wang J; Yao Z; Bu W; Shi J
    ACS Nano; 2016 Mar; 10(3):3783-90. PubMed ID: 26910513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
    Hu F; Jia Q; Li Y; Gao M
    Nanotechnology; 2011 Jun; 22(24):245604. PubMed ID: 21508500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
    Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
    Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated GdF
    Dong L; Zhang P; Lei P; Song S; Xu X; Du K; Feng J; Zhang H
    ACS Appl Mater Interfaces; 2017 Jun; 9(24):20426-20434. PubMed ID: 28557419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agents.
    Zhu D; Liu F; Ma L; Liu D; Wang Z
    Int J Mol Sci; 2013 May; 14(5):10591-607. PubMed ID: 23698781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic PEGylated Pt3Co nanoparticles as a novel MR contrast agent: in vivo MR imaging and long-term toxicity study.
    Yin S; Li Z; Cheng L; Wang C; Liu Y; Chen Q; Gong H; Guo L; Li Y; Liu Z
    Nanoscale; 2013 Dec; 5(24):12464-73. PubMed ID: 24165858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.